| Circulating tumor cell detection technologies and clinical utility: Challenges and opportunities Z Habli, W AlChamaa, R Saab, H Kadara, ML Khraiche Cancers 12 (7), 1930, 2020 | 171 | 2020 |
| Emerging cytotoxic alkaloids in the battle against cancer: Overview of molecular mechanisms Z Habli, G Toumieh, M Fatfat, ON Rahal, H Gali-Muhtasib Molecules 22 (2), 250, 2017 | 164 | 2017 |
| Thymoquinone-based nanotechnology for cancer therapy: Promises and challenges F Ballout, Z Habli, ON Rahal, M Fatfat, H Gali-Muhtasib Drug discovery today 23 (5), 1089-1098, 2018 | 84 | 2018 |
| COVID-19 in-vitro Diagnostics: State-of-the-Art and Challenges for Rapid, Scalable, and High-Accuracy Screening Z Habli, S Saleh, H Zaraket, ML Khraiche Frontiers in bioengineering and biotechnology 8, 605702, 2021 | 49 | 2021 |
| Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms M Fatfat, I Fakhoury, Z Habli, R Mismar, H Gali-Muhtasib Life sciences 232, 116628, 2019 | 43 | 2019 |
| Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma M Houssein, M Fatfat, Z Habli, N Ghazal, S Moodad, H Khalife, M Khalil, ... Life sciences 251, 117639, 2020 | 15 | 2020 |
| Anticancer alkaloids: molecular mechanisms and clinical manifestations F Ballout, Z Habli, A Monzer, ON Rahal, M Fatfat, H Gali-Muhtasib Bioactive Natural Products for the Management of Cancer: from Bench to …, 2019 | 12 | 2019 |
| Biomimetic sulfated glycosaminoglycans maintain differentiation markers of breast epithelial cells and preferentially inhibit proliferation of cancer cells Z Habli, NN Al Deen, W Malaeb, N Mahfouz, A Mermerian, R Talhouk, ... Acta Biomaterialia 122, 186-198, 2021 | 8 | 2021 |
| Advances in point-of-care platforms for traumatic brain injury: recent developments in diagnostics Z Habli, F Kobeissy, ML Khraiche Reviews in the Neurosciences 33 (3), 327-345, 2022 | 7 | 2022 |
| Circulating tumor cell detection technologies and clinical utility: challenges and opportunities. Cancers (Basel). 2020; 12 (7): 1930 Z Habli, W AlChamaa, R Saab, H Kadara, ML Khraiche | 5 | |
| Development of Inkjet-Printed PEDOT: PSS-Based Organic Electrochemical Transistor (OECT) for Biopotential Amplification FC Khoury, SA Saleh, ZS Habli, ML Khraiche 2023 45th Annual International Conference of the IEEE Engineering in …, 2023 | 2 | 2023 |
| Single-cell fluid-based force spectroscopy reveals near lipid size nano-topography effects on neural cell adhesion Z Habli, R Lahoud, A Zantout, W Abou-Kheir, ML Khraiche Lab on a Chip 24 (4), 707-718, 2024 | 1 | 2024 |
| Investigating malignancy-dependent mechanical properties of breast cancer cells Z Habli, A Zantout, M El-Sabban, ML Khraiche 2023 45th Annual International Conference of the IEEE Engineering in …, 2023 | 1 | 2023 |
| Electrochemical Detection of NT-Probnp Using High Performance Fully Inkjet-Printed Organic Electrochemical Transistors F Khoury, Z Habli, P Karam, S Alam, M Khraiche 245th ECS Meeting (May 26-30, 2024), 2024 | | 2024 |
| Single cell biomechanical profiling of the metastatic potential of MDA-MB-231 cells Z Habli, A Zantout, NA Hajj, R Saab, M El-Sabban, ML Khraiche Cancer Research 84 (6_Supplement), 2748-2748, 2024 | | 2024 |
| Future of nanoscience in natural product drug discovery: applications in thymoquinone-based nanoformulations H Gali-Muhtasib, Z Habli, F Ballout Nanobiotechnology, 25, 2018 | | 2018 |
| Biomimetic Sulfated GAGs Maintain Differentiation Markers of Breast Epithelial Cells and Preferentially Inhibit Proliferation of Cancer Cells Z Habli, NNA Deen, W Malaeb, N Mahfouz, A Mermerian, R Talhouk, ... Available at SSRN 3688763, 0 | | |
Massoud L KhraicheAmerican University of Beirut在 aub.edu.lb 的电子邮件经过验证
